Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Orasis Pharmaceuticals is an ophthalmic pharmaceutical company that develops eye drops for the treatment of presbyopia.
SonarMD provides care management for chronic conditions that use drugs.
Pharaoh Neuro develops a neurapheresis cerebrospinal fluid management system for neurological patients.
AtaCor Medical is a medical device maker.
Boomerang Medical is a bioelectronic medical enterprise.
Reprieve Cardiovascular is focused on improving outcomes for patients suffering from acute decompensated heart failure.
Allay Therapeutics offers analgesic products for post-surgical pain management and recuperation.
Akadeum develops bioseparation products to facilitate the removal of target cells from biological samples.
Fifth Eye develops a medical device software that provides a view of a patient’s evolving hemodynamic trajectory.
Francis Medical is a medical technology company developing therapeutic solutions to treat prostate, kidney, and bladder cancer.
Motif Neurotech is a company that develops minimally invasive bioelectronic implants for monitoring and treating severe mental illnesses.
Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases.
Delphinus Medical Technologies develops, commercializes, and services breast cancer screening solutions to hospitals and imaging clinics.
Convergent Dental develops a computer-guided, laser-based drilling, and cutting system for dentists.
Navv Systems is a provider of indoor location technology for hospitals and health systems.
Enumera Molecular is developing a scalable biomolecule assessment platform enabling lower-cost, rapid clinical liquid biopsy tests.
ConcertoCare is a provider of at-home and comprehensive care for seniors and other adults.
Health Scholars is a provider of virtual reality clinical training to both healthcare and public safety providers.
Swift Biosciences develops molecular biology reagents for research and diagnostic applications.
NeuMoDx Molecular, Inc. operates as a molecular diagnostics company. The company develops solutions for molecular diagnostic (MDx) testing
Arboretum Ventures has invested in 45 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Arboretum Ventures's top investment sectors include Health Care, Medical, Biotechnology, Medical Device, Pharmaceutical. The firm invests across 20 different industry categories.
Among tracked funding rounds, ConcertoCare received $105.0M in a Series B round. Arboretum Ventures's total known invested capital is $1.7B.
Arboretum Ventures's average investment size is $32.4M across its portfolio of 45 companies.
Recent Arboretum Ventures portfolio additions include Orasis Pharmaceuticals, SonarMD, Pharaoh Neuro, AtaCor Medical, Boomerang Medical. These companies were founded in 2020 or later.